Clinical trials
Leukemia, Hairy Cell trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2015 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 8 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 8 |
| Barbara Ann Karmanos Cancer Institute | 2 |
| City of Hope Medical Center | 2 |
| OHSU Knight Cancer Institute | 2 |
| Wake Forest University Health Sciences | 2 |
| Case Comprehensive Cancer Center | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Martin, Paul | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Hairy Cell | 25 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 25 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 25 |
| Burkitt Lymphoma | 24 |
| Lymphoma, B-Cell, Marginal Zone | 24 |
| Lymphoma, Follicular | 24 |
| Lymphoma, Large B-Cell, Diffuse | 24 |
| Lymphoma, Non-Hodgkin | 24 |
| Lymphoma, Large-Cell, Immunoblastic | 23 |
| Lymphoma, Mantle-Cell | 23 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.